Skip to content
healthcare.dev

THEOPHYLLINE

NDC 69315-226, THEOPHYLLINE, tablet, extended release, from Leading Pharma, LLC.

Product NDC
69315-226
Status
Listed
Labeler
Leading Pharma, LLC
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214950
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69315-226 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • THEOPHYLLINE300 mg/1

Pharmacologic classes

Methylxanthine [EPC]; Xanthines [CS]

Package NDCNDC-11Package
69315-226-0169315022601100 TABLET, EXTENDED RELEASE in 1 BOTTLE (69315-226-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ac490ebf-24e1-47c4-a932-ad4dcafe7aad
  • NADAC price for package 69315022601

    GET /v1/drugs/nadac/69315022601

Use it

Look up 69315-226 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69315-226 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69315-226. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.